350 related articles for article (PubMed ID: 6787836)
1. Plasma and urinary catecholamines and metabolites during physical exercise in essential hypertension.
Chodakowska J; Wocial B; Skórka B; Nazar K; Chwalbińska-Moneta J
Acta Physiol Pol; 1980; 31(6):623-30. PubMed ID: 6787836
[TBL] [Abstract][Full Text] [Related]
2. Changes in the excretion of catecholamines and their metabolites in patients with essential hypertension during sodium intake restriction.
Wocial B; Januszewicz W; Chodakowska J; Feltynowski T
Cor Vasa; 1981; 23(3):222-8. PubMed ID: 6790225
[TBL] [Abstract][Full Text] [Related]
3. Sympathetic reactivity to upright posture in borderline and established hypertension.
Januszewicz W; Sznajderman M; Wocial B; Chodakowska J; Feltynowski T; Zukowska-Grójec Z
Cor Vasa; 1982; 24(6):429-40. PubMed ID: 7184697
[TBL] [Abstract][Full Text] [Related]
4. Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension.
Ignatowska-Switalska H; Wocial B; Skórka B; Chodakowska J; Nazar K; Chwalbińska-Moneta J
Acta Physiol Pol; 1980; 31(6):631-5. PubMed ID: 7018172
[TBL] [Abstract][Full Text] [Related]
5. Increased urinary dopamine excretion in young patients with essential hypertension.
Saito I; Itsuji S; Takeshita E; Kawabe H; Nishino M; Wainai H; Hasegawa C; Saruta T; Nagano S; Sekihara T
Clin Exp Hypertens; 1994 Jan; 16(1):29-39. PubMed ID: 8136773
[TBL] [Abstract][Full Text] [Related]
6. Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques.
Pedersen EB; Christensen NJ
Acta Med Scand; 1975 Nov; 198(5):373-7. PubMed ID: 1199813
[TBL] [Abstract][Full Text] [Related]
7. Relationship between plasma renin activity and urinary catecholamines in various types of hypertension.
Horký K; Kopecká J; Greogorová I; Dvoráková J
Endokrinologie; 1976 Jul; 67(3):331-42. PubMed ID: 976208
[TBL] [Abstract][Full Text] [Related]
8. Dopa, catecholamines and their metabolites in essential hypertension.
Januszewicz W; Wocial B
Clin Sci Mol Med Suppl; 1975 Jun; 2():295s-298s. PubMed ID: 1077780
[TBL] [Abstract][Full Text] [Related]
9. Decreased platelet-free dopamine and unchanged noradrenaline and adrenaline in essential hypertension.
Kjeldsen SE; Gjesdal K; Leren P; Eide IK
Thromb Haemost; 1988 Oct; 60(2):251-4. PubMed ID: 3217920
[TBL] [Abstract][Full Text] [Related]
10. [Catecholamines, their precursors and metabolites in human fatigue after exertion].
Matlina EA; Vasil'ev VN; Galimov SD
Vopr Med Khim; 1977; (3):369-75. PubMed ID: 888403
[TBL] [Abstract][Full Text] [Related]
11. [Urinary excretion of the catecholamines adrenaline, noradrenaline and dopamine as well as the derivatives metanephrine and normetanephrine in heart disease patients].
Mäurer W; Yoshida Y; Kübler W
Z Kardiol; 1976 Dec; 65(12):1124-38. PubMed ID: 1014804
[TBL] [Abstract][Full Text] [Related]
12. Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension.
Kjeldsen SE; Flaaten B; Eide I; Helgeland A; Leren P
Scand J Clin Lab Invest; 1982 May; 42(3):217-23. PubMed ID: 7134805
[TBL] [Abstract][Full Text] [Related]
13. An increase in urinary catecholamines of renal origin in patients with "borderline" hypertension.
Kuchel O; Cuche JL; Buu NT; Genest J
Am J Med Sci; 1976; 272(3):263-8. PubMed ID: 1015511
[TBL] [Abstract][Full Text] [Related]
14. Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.
Carlsen JE; Trap-Jensen J; Svendsen TL; Nielsen PE; Rasmussen S; Christensen NJ
Postgrad Med J; 1980; 56 Suppl 2():43-8. PubMed ID: 7433342
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma].
Wocial B; Januszewicz W; Gryglas P; Januszewicz A; Feltynowski T; Lapiński M
Przegl Lek; 1997; 54(11):793-8. PubMed ID: 9501691
[TBL] [Abstract][Full Text] [Related]
16. Plasma catecholamines and production of thromboxane B2 by platelets after psychological and physical tests in normotensive and mild hypertensive subjects.
Vapaatalo H; Tuomisto M; Turjanmaa V; Metsä-Ketelä T; Fredrikson M; Uusitalo A
Biomed Biochim Acta; 1988; 47(10-11):S294-8. PubMed ID: 3248115
[TBL] [Abstract][Full Text] [Related]
17. Catecholamine metabolism in heart failure patients and healthy control subjects.
Lehmann M; Hasenfuss G; Samek L; Gastmann M
Arzneimittelforschung; 1990 Dec; 40(12):1310-8. PubMed ID: 2095127
[TBL] [Abstract][Full Text] [Related]
18. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
Sakuma N; Nagasaka N
ASDC J Dent Child; 1996; 63(2):118-22. PubMed ID: 8708120
[TBL] [Abstract][Full Text] [Related]
19. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
Vasil'ev VN
Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
[TBL] [Abstract][Full Text] [Related]
20. Excretion of catecholamines and metabolites in response to increased dietary phosphate intake.
Berndt TJ; MacDonald A; Walikonis R; Chinnow S; Dousa TP; Tyce GM; Knox FG
J Lab Clin Med; 1993 Jul; 122(1):80-4. PubMed ID: 8320494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
